20/20 Biolabs, Inc. — filings

CIK 1139685

Aggregates

computed from the filings below
Documents on record
8
Form types used
3
Filed in last 12 months
8
Median interval
3 d
between consecutive filings
Most used form
8-K
5 filings
Most recent filing
2026-09-18
Filed on a Friday
2
of the filings shown
Earliest shown
2026-07-01

By form type

FormFilingsMost recent
8-K52026-09-18
424B322026-08-17
10-Q12026-08-14

Documents

8 most recent shown
FiledFormAccessionSource
2026-09-188-K0001213900-26-101405document
2026-08-198-K0001213900-26-091438document
2026-08-17424B30001213900-26-090758document
2026-08-17424B30001213900-26-090765document
2026-08-178-K0001213900-26-090746document
2026-08-1410-Q0001213900-26-090042document
2026-07-228-K0001213900-26-080432document
2026-07-018-K0001213900-26-074182document

Source: U.S. Securities and Exchange Commission, EDGAR

20/20 Biolabs, Inc. filings — 8 documents on record — investment.com